As cancer care improves, more people are living with survivorship symptoms, such as fatigue and depression. See 3 ways providers can help patients prepare for life after treatment.
Holiday parties don't have to come with an extra helping for food guilt. Nutrition experts at UT Southwestern offer practical tips to enjoy holiday favorites in a healthy way.
An “illuminating” agent discovered by UT Southwestern and developed by OncoNano Medicine, Inc., spotlights peritoneal tumors, helping surgeons find and remove more metastatic cancer.
Metastatic bone disease patients find hope with orthopaedic surgery options to decrease fracture risk, improve mobility, and manage pain. Alexandra Callan, M.D., discusses treatment advances and paradigm shifts over the last decade.
A novel treatment may reverse resistance to both endocrine therapy and radiation therapy in breast cancer patients. Learn more from UT Southwestern radiation oncologists.
Theragnostics, an advanced combination of diagnostic and targeted therapy technology, uses radiopharmaceuticals to seek, find, and eliminate metastatic cancer cells while sparing healthy tissue. It is now available at UT Southwestern for pancreatic, thyroid, and several other cancers.
Robotic-assisted Whipple surgery for pancreatic cancer is one of the most complex GI procedures – and UT Southwestern is a leader in this field, training U.S. and international surgeons. Explore our Simulation Center and how robotic surgery can benefit patients.
UT Southwestern has developed a simple blood test that can predict which patients with nonalcoholic fatty liver disease are most likely to develop liver cancer.
UT Southwestern has been ranked the No. 1 hospital in North Texas for the six years in a row, and ranked nationally for 9 specialties areas of health care.
A groundbreaking study showed a 100% response to immunotherapy for a type of rectal cancer. See what the findings mean, who might benefit, and what’s next.